Health X Platform
HEALTHX NSE
Health X Platform
Healthcare ServicesNSE: HEALTHX BSE: 533259 Healthcare Service Provider
Key Fundamentals
MicrocapHealthcare Service ProviderHealthcare ServicesMarket Cap
₹942 Cr
Volatility
Moderate
P/E Ratio
37.63
EBITDA
₹-53.24 Cr
Return on Equity
-15.45%
Debt to Equity
0
Book Value
₹201.47
EPS
₹11.87
52W High
₹363
52W Low
₹252.5
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
4- Company is almost debt free.
- Company has delivered good profit growth of 23.3% CAGR over last 5 years
- Company's median sales growth is 39.5% of last 10 years
- Company's working capital requirements have reduced from 66.1 days to 47.0 days
Weaknesses
2- Company has a low return on equity of -1.12% over last 3 years.
- Earnings include an other income of Rs.66.2 Cr.
Growth Rate
Revenue Growth
12.68% higher than
3Y
Net Income Growth
-97.63% lower than
3Y
Cash Flow Change
-148% lower than
3Y
ROE
—
ROCE
751% higher than
3Y
EBITDA Margin (Avg.)
—
Quarterly Results
| Particulars | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 281 | 313 | 336 | 358 | 375 | 307 | 270 | 274 | 281 | 286 | 298 | 301 | 346 |
| Expenses | 291 | 324 | 327 | 355 | 371 | 317 | 273 | 278 | 305 | 311 | 292 | 324 | 356 |
| Operating Profit | -10.08 | -11.17 | 9.26 | 3.37 | 3.43 | -10.65 | -2.4 | -4.72 | -23.7 | -25.2 | 6.06 | -22.61 | -10.36 |
| OPM % | -3.59% | -3.57% | 2.76% | 0.94% | 0.92% | -3.47% | -0.89% | -1.73% | -8.43% | -8.82% | 2.03% | -7.5% | -3% |
| Other Income | 4.01 | 8.63 | 12.11 | 9.71 | 20.13 | 18.46 | 28.75 | -167 | -14.06 | 21.91 | 25.38 | 5.34 | 13.62 |
| Interest | 0.27 | 0.26 | 0.25 | 0.24 | 0.24 | 0.27 | 0.1 | 0.06 | 0.05 | 0.01 | 0.09 | 0.04 | 0.17 |
| Depreciation | 2.4 | 2.8 | 2.09 | 2.2 | 2.31 | 2.53 | 1.61 | 1.45 | 1.43 | 1.34 | 1.17 | 1.33 | 2.17 |
| PBT | -8.74 | -5.6 | 19.03 | 10.64 | 21.01 | 5.01 | 24.64 | -174 | -39.24 | -4.64 | 30.18 | -18.64 | 0.92 |
| Tax % | -70.48% | 287.5% | -28.85% | -23.03% | 3.86% | -583.03% | -102.8% | -13.17% | 1.99% | -478.45% | 11.9% | -17.17% | 59.78% |
| Net Profit | -26.37 | -48 | -0.28 | -12.2 | -3.23 | 21.58 | 40.96 | -155 | -37.8 | 17.57 | 26.59 | -15.44 | 0.37 |
| EPS in Rs | -6 | -10.75 | 0.41 | -2.55 | -0.24 | 5.17 | 9.79 | -34.39 | -8.47 | 4.3 | 7.52 | -3.99 | 0.36 |
Profit & Loss
| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30 | 52 | 89 | 135 | 162 | 222 | 388 | 551 | 1,798 | 1,060 | 1,432 | 1,159 | 1,231 |
| Expenses | 35 | 62 | 116 | 155 | 175 | 255 | 440 | 561 | 684 | 1,168 | 1,456 | 1,177 | 1,283 |
| Operating Profit | -4 | -10 | -28 | -20 | -13 | -33 | -52 | -10 | 1,114 | -107 | -24 | -19 | -52 |
| OPM % | -15% | -19% | -31% | -15% | -8% | -15% | -13% | -2% | 62% | -10% | -2% | -2% | -4% |
| Other Income | 0 | 2 | 0 | 2 | 7 | 0 | 1 | 1 | 3 | -5 | 4 | -179 | 66 |
| Interest | 1 | 1 | 2 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 | 0 | 0 |
| Depreciation | 2 | 6 | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 | 6 | 6 |
| PBT | -7 | -15 | -37 | -28 | -12 | -42 | -58 | -16 | 1,109 | -122 | -30 | -204 | 8 |
| Tax % | -5% | 0% | -1% | 2% | 19% | 3% | -9% | 4% | 22% | -19% | -119% | -34% | — |
| Net Profit | -6 | -15 | -37 | -29 | -15 | -43 | -52 | -17 | 865 | -99 | 6 | -134 | 29 |
| EPS in Rs | -2.03 | -4.68 | -11.51 | -9 | -3.73 | -11.81 | -12.19 | -3.27 | 197 | -22.7 | 2.79 | -28.66 | 8.19 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 238 | 223 | 186 | 163 | 144 | 111 | 178 | 168 | 795 | 722 | 731 | 638 | 650 |
| Borrowings | 0 | 5 | 19 | 21 | 12 | 2 | 8 | 12 | 2 | 9 | 4 | 1 | 5 |
| Other Liabilities | 39 | 22 | 20 | 35 | 48 | 86 | 98 | 80 | 449 | 441 | 383 | 300 | 321 |
| Total Liabilities | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 1,008 |
| Fixed Assets | 117 | 137 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 | 117 |
| CWIP | 0 | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 | 1 |
| Investments | 41 | 22 | 10 | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 676 | 575 | 633 |
| Other Assets | 151 | 119 | 120 | 110 | 71 | 77 | 146 | 139 | 518 | 583 | 363 | 283 | 257 |
| Total Assets | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 1,008 |
Cash Flow
| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 36 | -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 36 | -17 |
| Investing | -42 | 7 | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 133 | -34 | -1 |
| Financing | -3 | 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | 0 |
| Net Cash Flow | -10 | -1 | 0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 | 0 | -19 |
| Free Cash Flow | 15 | -28 | -18 | 0 | -55 | -33 | -71 | -31 | -212 | -128 | 22 | -27 |
| CFO/OP | -845 | 106 | 43 | 17 | 377 | 89 | 133 | 288 | -8 | 104 | -172 | 68 |
Ratios
| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 169 | 87 | 34 | 52 | 9 | 13 | 14 | 9 | 4 | 12 | 9 | 3 |
| Inventory Days | — | 337 | 91 | 80 | 73 | 59 | 77 | 57 | 71 | 69 | 34 | 40 |
| Days Payable | — | 165 | 38 | 69 | 24 | 26 | 50 | 29 | 21 | 22 | 13 | 21 |
| Cash Conversion Cycle | 169 | 259 | 87 | 62 | 58 | 46 | 41 | 38 | 55 | 59 | 31 | 22 |
| Working Capital Days | 441 | 344 | 182 | 49 | 61 | 61 | 54 | 44 | 46 | 93 | 58 | 47 |
| ROCE % | -2% | -6% | -14% | -12% | -8% | -19% | -25% | -6% | -7% | -11% | -3% | -1% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Health X Platform insights
64 extracted metrics + investor summaries across FY11–FY26.
Documents
1
Approval From Stock Exchange For Change In Name And Symbol
25 Apr - BSE and NSE approved name change to Health X Platform Limited, effective April 30, 2026. 25 Apr - BSE and NSE approved name change to Health X Platform Limited, effective April 30, 2026.
2
Approval From Stock Exchange For Change In Name And Symbol
10h - BSE and NSE approved name change to Health X Platform Limited, effective April 30, 2026. 10h - BSE and NSE approved name change to Health X Platform Limited, effective April 30, 2026.
3
Update On Application To Stock Exchanges For Change In Name Of The Company
24 Apr - Revised CA certificate filed to support name change to Health X Platform Limited. 24 Apr - Revised CA certificate filed to support name change to Health X Platform Limited.
4
Update On Application To Stock Exchanges For Change In Name Of The Company
10h - Revised CA certificate filed to support name change to Health X Platform Limited. 10h - Revised CA certificate filed to support name change to Health X Platform Limited.
5
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
6 Apr - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Reg, 2018 for the quarter ended March 31, 2026. 6 Apr - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Reg, 2018 for the quarter ended March 31, 2026.
Frequently Asked Questions about Health X Platform
What does Sastasundar Ventures Ltd do?
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]
Where is Sastasundar Ventures Ltd (SASTASUNDR) listed?
Sastasundar Ventures Ltd trades as HEALTHX on the NSE and under code 533259 on the BSE.
Which sector does Sastasundar Ventures Ltd belong to?
Sastasundar Ventures Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd has a market capitalisation of ₹941.59 Cr, which places it in the Small Cap band.
What is the PE ratio of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd trades at a PE ratio of 37.63, on earnings per share of ₹11.87, against a book value of ₹201.47 per share.
What is the 52-week high and low of Sastasundar Ventures Ltd?
Over the last 52 weeks Sastasundar Ventures Ltd has traded between ₹252.5 and ₹363.
What is the Return on Equity (ROE) of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd reported a return on equity of -15.45%. Its debt-to-equity ratio is 0.00.
Company Information
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]
Website sastasundarventures.com
CEO Mr. Banwari Lal Mittal
Employees 1,657
Listed 2010-10-05
Face Value ₹ 10
Issued Size 3,18,10,500
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SASTASUNDR.md for Sastasundar Ventures Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.